Neuralink
Search results
As the leader in non-invasive neuroimaging, Kernel believes in data-driven development and scalable technology. Our brain-based biomarkers, action-focused solutions, and reliable data can empower and accelerate your goals.
- Vision & Team
As the leader in non-invasive neuroimaging, Kernel believes...
- News
Kernel Launches Observational Study Using Flow2 Neuroimaging...
- Vision & Team
As the leader in non-invasive neuroimaging, Kernel believes in data-driven development and scalable technology. Our brain-based biomarkers, action-focused solutions, and reliable data can empower and accelerate your goals.
Kernel is a technology company that creates brain–machine interfaces. It is a privately held company headquartered in Los Angeles, California. The company was founded in 2016 by Bryan Johnson. [1] [2] History.
Kernel's category-defining neuroimaging platform can be used to accelerate treatment development, improve patient outcomes, and reduce healthcare costs.
Jul 20, 2023 · Kernel Launches Observational Study Using Flow2 Neuroimaging Technology to Identify Biomarkers of Depression Treatment Response. August 29, 2023. The study utilizes Flow2 to measure patients as they undergo treatment, paving the way to transform how depression is treated with patient-specific biomarkers. Read More.
The company's platform is focused on treating dysfunctions caused by neurodegenerative diseases by utilizing human intelligence to develop a neuroprosthetic to mimic, repair, and improve cognition, enabling clients to access brain imaging devices and the ability to perform experiments remotely.
Jul 9, 2020 · LA-based bio science startup Kernel has raised $53 million from investors, including General Catalyst, Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny.
